Detalhe da pesquisa
1.
Functional genomic landscape of acute myeloid leukaemia.
Nature
; 562(7728): 526-531, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30333627
2.
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.
Cancer Cell
; 40(8): 850-864.e9, 2022 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35868306
3.
Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis.
Leuk Res
; 131: 107331, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37263072
4.
Targeting of colony-stimulating factor 1 receptor (CSF1R) in the CLL microenvironment yields antineoplastic activity in primary patient samples.
Oncotarget
; 9(37): 24576-24589, 2018 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29872489
5.
Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma.
Oncotarget
; 6(22): 18921-32, 2015 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26254279
6.
Acid-sensing ion channels in mouse olfactory bulb M/T neurons.
J Gen Physiol
; 143(6): 719-31, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24821964